Patent · US Active

Anti-Axl antagonistic antibodies

US11584796B2 · kind B2 · utility

0Cited by
7References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 19, 2018
Grant dateFeb 21, 2023
Priority date
Expiry dateMar 4, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described are antibodies that specifically bind to the Axl protein and inhibit the interaction between Axl and the Axl-ligand, Gas6. Also disclosed are methods for the production and use of the anti-Axl antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.